LINXERA owner Contact Information online
from Ironwood Pharmaceuticals, Inc.
LINXERA
US serial number:85037032
Application filling date:May 12, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jan. 13, 2014
Publication date:Oct. 12, 2010
Abandoned date:Jan. 13, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for use in the treatment of chronic constipation, irritable bowel syndrome, gastrointestinal motility disorders and other gastrointestinal disorders
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,04
Services:Pharmaceutical preparations for use in the treatment of chronic constipation
irritable bowel syndrome
gastrointestinal motility disorders and other gastrointestinal disorders
Current owner owner name:Ironwood Pharmaceuticals, Inc.
Current owner owner address:301 Binney Street
Cambridge,
MASSACHUSETTS
UNITED STATES
02142
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Michael J. Bevilacqua, Esquire
Attorney email:michael.bevilacqua@wilmerhale.com
Attorney docket number:109.272.154
Attorney email authorized:Yes
Correspondent name address:MICHAEL J. BEVILACQUA, ESQUIRE
WILMER CUTLER PICKERING HALE AND DORRLLP
60 STATE ST
BOSTON,
MASSACHUSETTS
UNITED STATES
02109
Correspondent phone:617-526-6448
Correspondent email:michael.bevilacqua@wilmerhale.com
Correspondent fax:617-526-5000
Correspondent email authorized:Yes
Trademark staff tm attorney:DINALLO, KEVIN M
Trademark staff law office assigned LINXERA:LAW OFFICE 107
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (125) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Bayer Aktiengesellschaft (46) Windmill Health Products, LLC (46) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) MERCK SHARP & DOHME CORP. (28) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Oct. 12, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
